Phase III trial of REGN3470-3471-3479 in patients with Ebola virus infection
Latest Information Update: 24 May 2019
At a glance
- Drugs Atoltivimab/maftivimab/odesivimab (Primary)
- Indications Ebola virus infections
- Focus Therapeutic Use
Most Recent Events
- 24 May 2019 New trial record